Literature DB >> 3909378

Relationship of schizotypal personality disorder to schizophrenia: genetics.

S Torgersen.   

Abstract

The adoptive, family, and twin studies show that schizotypal personality features are found among the relatives of schizophrenics. However, it has not been shown that there is a higher risk of schizophrenia among the relatives of schizotypals. An explanation may be that the current DSM-III criteria of schizotypal personality disorder do not adequately define schizotypals genetically related to schizophrenia. While some of the cases that meet DSM-III criteria are within the schizophrenia spectrum, others are unrelated to schizophrenia. There is reason to believe that schizotypals characterized by distant relationship to others, suspiciousness, eccentricity, peculiar communication, and dysfunctional school and work performance are within the schizophrenic sphere, while individuals with psychotic-like symptoms phenomenologically similar to schizophrenia and diagnosed as schizotypal personality disorders in DSM-III represent decompensation of other personality disorders.

Entities:  

Mesh:

Year:  1985        PMID: 3909378     DOI: 10.1093/schbul/11.4.554

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

Review 1.  Schizotaxia: current status and future directions.

Authors:  Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

3.  Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders.

Authors:  Jennifer K Forsyth; Amanda R Bolbecker; Crystal S Mehta; Mallory J Klaunig; Joseph E Steinmetz; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2010-12-09       Impact factor: 9.306

4.  Stressful life events as predictors of functioning: findings from the collaborative longitudinal personality disorders study.

Authors:  M E Pagano; A E Skodol; R L Stout; M T Shea; S Yen; C M Grilo; C A Sanislow; D S Bender; T H McGlashan; M C Zanarini; J G Gunderson
Journal:  Acta Psychiatr Scand       Date:  2004-12       Impact factor: 6.392

5.  Tailoring the definition of the clinical schizophrenia phenotype in linkage studies.

Authors:  Verena Krause; Olga Krastoshevsky; Michael J Coleman; J Alexander Bodkin; Jan Lerbinger; Lenore Boling; Fred Johnson; Anne Gibbs; Jonathan O Cole; Zhuying Huang; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Res       Date:  2009-11-26       Impact factor: 4.939

6.  Testing Liddle's three-syndrome model in families with schizophrenia.

Authors:  A S Bassett; A Bury; W G Honer
Journal:  Schizophr Res       Date:  1994-06       Impact factor: 4.939

7.  Schizophrenia: vulnerability versus disease.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

8.  Characterization of the Fiber Connectivity Profile of the Cerebral Cortex in Schizotypal Personality Disorder: A Pilot Study.

Authors:  Kai Liu; Teng Zhang; Qing Zhang; Yueji Sun; Jianlin Wu; Yi Lei; Winnie C W Chu; Vincent C T Mok; Defeng Wang; Lin Shi
Journal:  Front Psychol       Date:  2016-05-30

9.  Co-morbidity of personality disorder in schizophrenia among psychiatric outpatients in China: data from epidemiologic survey in a clinical population.

Authors:  YanYan Wei; TianHong Zhang; Annabelle Chow; YingYing Tang; LiHua Xu; YunFei Dai; XiaoHua Liu; Tong Su; Xiao Pan; Yi Cui; ZiQiang Li; KaiDa Jiang; ZePing Xiao; YunXiang Tang; JiJun Wang
Journal:  BMC Psychiatry       Date:  2016-07-08       Impact factor: 3.630

10.  Lifetime prevalence and potential determinants of psychotic experiences in the general population of Qatar.

Authors:  Salma M Khaled; Stacy Schantz Wilkins; Peter Woodruff
Journal:  Psychol Med       Date:  2019-05-28       Impact factor: 7.723

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.